Pursuant to Regulation 29 read with other applicable Regulation of the of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Trident Texofab has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, February 12, 2026 at the registered office of the Company, to consider and approve including: Unaudited standalone financial results of the Company for the quarter and Nine Month ended on December 31, 2025 and Any other business with the permission of the Chair. Further, Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, read with Code of Conduct framed by the Company and in continuation to our letter dated December 30,2025, the Trading Window for trading in the Company's equity shares was closed from January 01, 2026 and shall reopen 48 hours after the results of the meeting are made public on February 12,2026.

The above information is a part of company’s filings submitted to BSE.